Association of IFNAR2 and TYK2 with COVID-19 pathology: current and future.

Razavi, Alireza; Raei, Maedeh; Shirato, Ken

Razavi, Alireza; Raei, Maedeh; Shirato, Ken.

Afiliação

Razavi A; Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Raei M; Research Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Shirato K; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Front Immunol ; 15: 1462628, 2024.

Article em En | MEDLINE | ID: mdl-39351231

Assuntos

COVID-19; Receptor de Interferon alfa e beta; SARS-CoV-2; TYK2 Quinase; Humanos; COVID-19/imunologia; SARS-CoV-2/fisiologia; TYK2 Quinase/metabolismo; TYK2 Quinase/genética; Receptor de Interferon alfa e beta/metabolismo; Receptor de Interferon alfa e beta/genética

Palavras-chave

SARS coronavirus 2; coronavirus disease 2019; interferon alpha-beta receptor subunit 2 (IFNAR2); prognostic factor; tyrosine kinase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: TYK2 Quinase / Receptor de Interferon alfa e beta / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google